Celesq® Attorneys Ed Center
Print Catalog:

Programs in Biotechnology & Life Sciences


Our checkout cart is not currently working properly. In an effort to continue addressing your CLE needs, we would like to offer you a manual solution. Please go through our programs list. If you see a program that you would like to take to help satisfy your CLE needs, and it is past the program date (future dates are not yet available, of course), please send us the name of the program and the program number associated with it.

We will send you: 1) the audio file 2) the pdf of the presentation materials and 3) a manual affirmation form that you can fill out affirming that you listened to the entire program.

Once we receive the affirmations from you, we will issue manual certificates that you will be able to use to certify your CLE requirements.

Thank you so much and we apologize for the extreme inconvenience.

Please email customer.care@celesq.com with the above mentioned requests and we will get back to you as soon as possible!

Filter by State
Filter by Category

Reducing Regulatory and Liability Risks by Preparing for an FDA Facility Inspection and Responding to a 483 Letter (09/01/2020)

Program Number: 30210 Presenter: J. Lee Gray, Esq., Brent Johnson, Esq., Kristy M. Kimball, Esq.

In addition to evaluating data from adverse event reports, the bulk of FDA's regulatory enforcement comes from its facility inspections and resulting 483 reports. Such regulatory enforcement actions not only carry financial risks of regulatory non-compliance, but can also directly impact product liability risks as well. This practical webinar will cover numerous aspects of preparing your drug or medical device establishment for a successful FDA facility inspection and responding to any post-inspection 483 letters. The key to a successful inspection strategy is adequate preparation and implementing the inspection plan before FDA knocks on your door. Attendees will learn: • Potential product liability issues stemming from a 483 report; • What to expect during the inspection; • Strategies for preparing for an inspection; • What to expect after the inspection; and *Strategies for responding to any deficiencies noted in a 483 report

$95.00Audio Tape Add to Cart

In the Cannabis Industry, Profitability and Data Privacy/Security go Hand-in-Hand (09/17/2020)

Program Number: 30200 Presenter: Rebecca L. Rakoski, Esq.

As the legalized cannabis industry takes its place amongst other highly highly profitable mainstream businesses it is impossible to overlook the cybersecurity and data privacy issues that uniquely affect the industry and its profitability. The issues surrounding legalized cannabis and data security create a multi-front battle that can be incredibly challenging from a legal and technological perspective. The fact that the cannabis industry has intertwining issues of highly sensitive data, regulatory oversight and mandatory data collection requirements creates a very distinctive challenge for the profitability of those businesses. But many of those challenges can be addressed using some of the same practices and solutions. Preserving profit margins and exploring innovation are fundamental to staying solvent in an industry driven to deliver results. This presentation will explore the industry-specific challenges that face legalized cannabis businesses including regulatory obligations, such as the California Cannabis Track-and-Trace ("CCTT") system, the Health Insurance Portability and

$95.00Audio Tape Add to Cart

Making Waves: The Ripple Effects of the Supreme Court’s New “Functional Equivalent” Test on Clean Water Act NPDES Discharge Permitting (08/10/2020)

Program Number: 30191 Presenter: Megan Elliott, Esq., Bryan Franey, Esq., Brenda Gotanda, Esq.

Resolving a hotly contested split in the lower courts as to whether a Clean Water Act NPDES permit is required for indirect discharges to navigable waters, the U.S. Supreme Court’s recent decision in County of Maui, Hawaii v. Hawaii Wildlife Fund is likely to have significant ripple effects beyond its initial impact. Dischargers, agencies and courts may now confront considerably more complex technical and legal issues arising from the migration of pollutants through groundwater to surface waters. Join us for a discussion that analyzes key aspects of the Supreme Court’s decision and its newly-crafted “functional equivalent” test and explores the potential implications of the change in Clean Water Act jurisprudence on current and future permitting, enforcement and litigation matters.

$95.00Audio Tape Add to Cart

Unraveling the Legal Complexities of Hemp and CBD (07/10/2019)

Program Number: 2995 Presenter: Ian Stewart, Esq.

The hemp and CBD (cannabidiol) tidal wave continues despite significant confusion on the extent to which hemp and hemp-derived CBD are currently legal. This webinar digs into the fascinating world of the hemp and CBD markets both in the US and abroad. Attendees will receive a clear explanation of the current legality of hemp and CBD as we transition from the 2014 Farm Bill toward full implementation of the protections under the 2018 Farm Bill. The discussion will include how various states and federal agencies are adapting to hemp and CBD, including current limitations on interstate transportation and prohibitions under relevant food and drug laws. We will address common misconceptions relating to hemp and CBD, and identify risk management best practices that should be embraced by all current industry participants.

$95.00Online Audio Add to Cart

Wrongful Death Before Birth (09/17/2019)

Program Number: 29156 Presenter: Erika Amarante, Esq., Laura Ann Froning, Esq.

This presentation will review the circumstances under which an unborn fetus might assert a claim for wrongful death due to medical negligence. Not surprisingly, whether and when a fetus can legally assert a wrongful death claim differs dramatically in different states. The presentation will discuss the varying thresholds for recognizing such a claim, the legal consequences of such thresholds, and how attorneys who defend these lawsuits might approach a claim for wrongful death before birth.

$95.00Online Audio Add to Cart

High Times at FDA: The Federal and State Regulation of Cannabis (09/11/2019)

Program Number: 29138 Presenter: Mark Mansour, Esq.

The regulation of cannabis is one of the most controversial issues facing the U.S. Food and Drug Administration (FDA) and the states. FDA held a public meeting on May 31, 2019, and the result was inconclusive regarding next steps. This webinar will discuss the results of the webinar, prospects for federal legislation, developments in state legislation, and prospects for the coming years. We will also address questions such as whether the train has left the station regarding the marketing and sale of CBD, as well as what is next for THC. In addition, we will talk about the prospects for congressional action regarding marijuana. We hope you’ll join us for this discussion of a highly topical issue that is only going to receive more attention in the coming years.

$95.00Online Audio Add to Cart

IP Protection in Cannabis - How to Make it Happen Around the World! (10/16/2019)

Program Number: 29136 Presenter: David Postolski, Esq.

Cannabis- The intellectual property protection of cannabis and cannabis derivative products is currently exiting out of its Wild Wild West status and finally stabilizing in the US and around the world. Obtaining patent and trademark protection for these types of plants, products and services is a reality with the right strategies, due diligence and planning. This webinar will explore recent decisions in the US and from the around the world on what exactly can be protected today in this emerging field and what is on the horizon!

$95.00Online Audio Add to Cart

The Land of Lincoln (and Weed): An Analysis of Illinois’s Recreational Marijuana Law (07/23/2019)

Program Number: 29129 Presenter: Irina Dashevsky, Esq., Ryan M. Holz, Esq., Douglas R. Sargent, Esq., David Standa, Esq.

On May 31, 2019, Illinois passed the Cannabis Regulation and Tax Act, which legalizes recreational marijuana effective January 1, 2020. This webcast will break down the Act’s various components, providing detailed analysis of the key features of the legislation. The speakers will discuss the frenzy of activity that the passage of the Act is causing and their expectations for how the process will play out in both the short term and the long term.

$95.00Online Audio Add to Cart